Castle Biosciences (CSTL): Wasatch Advisors LP reduced its stake -30K shares

1.8M

Shares reported · -30K vs prior quarter

0.24%

Disclosed portfolio weight

$47.9M

Reported value

Holdings as of

Dec 31, 2024

Filed

Feb 13, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Dec 13, 2024Insider · 1 personInsiders: 14 sales (~$431K)
2. Dec 16, 2024InsiderDirector sold ~$319K of CSTL shares in the open market
3. Dec 17, 2024Insider · 1 personInsiders: 2 sales (~$265K)
4. Jan 6, 2025Insider · 3 peopleInsiders: 31 sales (~$505K)
5. Jan 7, 2025Insider · 1 personInsiders: 7 sales (~$19K)
6. Jan 13, 2025Insider · 1 personInsiders: 21 sales (~$72K)
7. Feb 5, 2025Insider · 1 personInsiders: 3 sales (~$222K)

What came next

1. Feb 20, 2025InsiderCFO sold ~$215K of CSTL shares in the open market

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Castle Biosciences

For Castle Biosciences, OQRO holds 31 insider filings (SEC Form 4 or Form 144), 1 fund holdings report (13F) and 1 federal contract award dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CSTL page.

How this filing works

• SEC Form 13F

Other disclosures at Castle Biosciences

• SEC Form 4Nov 13, 2026
• SEC Form 144Nov 12, 2026
• SEC Form 4Nov 12, 2026
• SEC Form 4Nov 12, 2026
• SEC Form 144Nov 9, 2026
• SEC Form 4Nov 4, 2026

Everything OQRO holds on this company is on its CSTL page.